Celldex Therapeutics shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.1M | 150k | 27.52 |
| 2023-06-30 | $3.0M | 87k | 33.93 |
| 2023-03-31 | $1.8M | 50k | 35.98 |
| 2022-12-31 | $4.9M | 110k | 44.57 |
| 2022-09-30 | $2.2M | 80k | 28.11 |
| 2022-06-30 | $5.0M | 185k | 26.95 |
| 2022-03-31 | $4.3M | 125k | 34.06 |
| 2021-12-31 | $3.9M | 100k | 38.64 |
| 2021-09-30 | $2.2M | 40k | 53.99 |
| 2021-06-30 | $1.7M | 50k | 33.44 |
| 2021-03-31 | $2.7M | 130k | 20.60 |
| 2020-12-31 | $1.3M | 75k | 17.52 |